Literature DB >> 18387767

Identification of major constituents in the traditional Chinese medicine "QI-SHEN-YI-QI" dropping pill by high-performance liquid chromatography coupled with diode array detection-electrospray ionization tandem mass spectrometry.

Li Yunfei1, Qu Haibin, Cheng Yiyu.   

Abstract

An HPLC-DAD-ESI-MS(n) method was developed for simultaneous analysis of major chemical constituents in "QI-SHEN-YI-QI" dropping pill, a traditional Chinese medicine (TCM) widely used for treating cardiovascular diseases. The chromatographic separation was performed on an intertsil ODS-3 C(18) column (4.6 mm x 250 mm, 5 microm), whilst water with 0.05% acetic acid and acetonitrile were used as mobile phase. On the basis of the characteristic UV absorption profile, the information of molecular weight, and structure provided by ESI-MS(n), 31 constituents derived from Astragalus membranaceus, Radix Salviae Miltiorrhizae, and Panax notoginseng, were detected and 20 of them were identified in this study. The proposed method contributes to the quality control of "QI-SHEN-YI-QI" dropping pill.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18387767     DOI: 10.1016/j.jpba.2007.12.037

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  14 in total

1.  A HPLC-DAD method for the simultaneous determination of five marker components in the traditional herbal medicine Bangpungtongsung-san.

Authors:  Jin Bae Weon; Hye Jin Yang; Jin Yeul Ma; Choong Je Ma
Journal:  Pharmacogn Mag       Date:  2011-01       Impact factor: 1.085

2.  Effect of QiShenYiQi Pill on Myocardial Collagen Metabolism in Rats with Partial Abdominal Aortic Coarctation.

Authors:  Shichao Lv; Meifang Wu; Meng Li; Qiang Wang; Xiaojing Wang; Ling Xu; Junping Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-11       Impact factor: 2.629

3.  QiShenYiQi Pill Improves Myocardial Hypertrophy Caused by Pressure Overload in Rats.

Authors:  Shichao Lv; Qiang Wang; Meifang Wu; Meng Li; Xiaojing Wang; Ling Xu; Junping Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-16       Impact factor: 2.629

4.  Recent methodology in ginseng analysis.

Authors:  Seung-Hoon Baek; Ok-Nam Bae; Jeong Hill Park
Journal:  J Ginseng Res       Date:  2012-04       Impact factor: 6.060

5.  Electrospray tandem mass spectrometric analysis of a dimeric conjugate, salvialeriafone and related compounds.

Authors:  Syed Ghulam Musharraf; Madiha Goher; Amjad Hussain; M Iqbal Choudhary
Journal:  Chem Cent J       Date:  2012-10-18       Impact factor: 4.215

6.  DNA extraction protocol for biological ingredient analysis of Liuwei Dihuang Wan.

Authors:  Xinwei Cheng; Xiaohua Chen; Xiaoquan Su; Huanxin Zhao; Maozhen Han; Cunpei Bo; Jian Xu; Hong Bai; Kang Ning
Journal:  Genomics Proteomics Bioinformatics       Date:  2014-05-14       Impact factor: 7.691

7.  Qi-shen-yi-qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial.

Authors:  Hongcai Shang; Junhua Zhang; Chen Yao; Baoyan Liu; Xiumei Gao; Ming Ren; Hongbao Cao; Guohua Dai; Weiliang Weng; Sainan Zhu; Hui Wang; Hongjuan Xu; Boli Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-14       Impact factor: 2.629

8.  A network pharmacology study of Chinese medicine QiShenYiQi to reveal its underlying multi-compound, multi-target, multi-pathway mode of action.

Authors:  Xiang Li; Leihong Wu; Wei Liu; Yecheng Jin; Qian Chen; Linli Wang; Xiaohui Fan; Zheng Li; Yiyu Cheng
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

9.  Effect and Mechanism of QiShenYiQi Pill on Experimental Autoimmune Myocarditis Rats.

Authors:  Shichao Lv; Meifang Wu; Meng Li; Qiang Wang; Ling Xu; Xiaojing Wang; Junping Zhang
Journal:  Med Sci Monit       Date:  2016-03-06

10.  Pharmacokinetic study of salvianolic acid D after oral and intravenous administration in rats.

Authors:  Junke Song; Wen Zhang; Jialin Sun; Xiaona Xu; Xue Zhang; Li Zhang; Zhangying Feng; Guan-Hua Du
Journal:  Acta Pharm Sin B       Date:  2015-04-27       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.